CRISPR uni­corn Mam­moth backs off di­ag­nos­tics re­search, lay­ing off 35 on test­ing team to fo­cus on ther­a­peu­tics

Mam­moth Bio­sciences is tak­ing a big step away from its orig­i­nal am­bi­tion of up­end­ing the di­ag­nos­tics busi­ness with CRISPR, and has laid off the bulk of its em­ploy­ees work­ing on test­ing.

The Bris­bane, CA-based start­up laid off 35 peo­ple, or less than 20% of its work­force, in March, Mam­moth CEO Trevor Mar­tin con­firmed to End­points News. The cuts have not been pre­vi­ous­ly re­port­ed, and pri­mar­i­ly af­fect­ed peo­ple work­ing on the di­ag­nos­tics team.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.